Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Sarepta Therapeutics, Inc. (SRPT) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$399.36M |
|
$-179.95M |
|
$150.78M |
|
$248.58M |
|
$502.75M |
|
$-103.39M |
|
$-90.66M |
|
$-194.05M |
|
$-194.05M |
|
$-179.95M |
|
$-179.95M |
|
$-179.95M |
|
$-179.95M |
|
$-103.39M |
|
$-86.07M |
|
100.24M |
|
100.24M |
|
$-1.80 |
|
$-1.80 |
|
| Balance Sheet Financials | |
$2.72B |
|
$358.94M |
|
$771.13M |
|
$3.49B |
|
$921.42M |
|
$1.04B |
|
$1.25B |
|
$2.17B |
|
$1.32B |
|
$1.32B |
|
$1.32B |
|
104.77M |
|
| Cash Flow Statement Financials | |
$-336.69M |
|
$-26.57M |
|
$-129.14M |
|
$1.12B |
|
$626.20M |
|
$-492.39M |
|
$93.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.44 |
|
0.78 |
|
62.25% |
|
-25.89% |
|
-25.89% |
|
-- |
|
-48.59% |
|
-45.06% |
|
$-435.07M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.14 |
|
1.01 |
|
89.18 |
|
-13.63% |
|
-13.63% |
|
-5.15% |
|
-7.64% |
|
$12.60 |
|
$-4.34 |
|
$-3.36 |
|